Skip to content
Screener

uniQure QURE Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$1.83M+51.6%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.58M+31.8%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$13.7M-38.9%
Regenxbio logo
RegenxbioRGNX
$486K-26.8%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$41M+136%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemJune 30, 2026December 31, 2025
Operating lease liabilities, net of current portion9,6969,832
Contingent consideration18,11318,736
Deferred tax liability, net7,7267,967
Other non-current liabilities, net of current portion2,6933,655
Total non-current liabilities577,708563,088
Total liabilities661,053626,007
Commitments and contingencies
Shareholders' equity

Item 1.Financial Statements

FAQ

What is uniQure's other non-current liabilities?
uniQure (QURE) reported other non-current liabilities of $2.69M in Q2 2026.
How has uniQure's other non-current liabilities changed year-over-year?
uniQure's other non-current liabilities decreased by 55.3% year-over-year, from $6.02M to $2.69M.
What is the long-term trend for uniQure's other non-current liabilities?
Over 5 years (2020 to 2025), uniQure's other non-current liabilities has grown at a 3.1% compound annual growth rate (CAGR), from $3.14M to $3.66M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about uniQure's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude